Tryptamine Therapeutics (ENP) Revenue

15 Followers

Statistics Revenue

Tryptamine Therapeutics Revenue

Tryptamine Therapeutics had a revenue of 0.00 in the quarter ending Aug 31, 2024, with ―. This bring the company's revenue in the last twelve months to 0.00, Decreased ―. In the fiscal year ending Aug 31, 2024, Tryptamine Therapeutics had annual revenue of 0.00 with ― growth.

Revenue (ttm)

0.00

Revenue Growth

―

P/S Ratio

―

Revenue/Employee

AU$0

Employees

Market Cap

AU$62.01M

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Aug 31, 2024	―	―	―
Jun 30, 2023	―	-618.57K	-100.00%
Jun 30, 2022	618.57K	518.84K	+520.24%
Jun 30, 2021	99.73K	―	+∞%
Jun 30, 2020	―	―	―
Jun 30, 2019	―	―	―
Jun 30, 2019	―	―	―
Jun 30, 2018	―	―	―